Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Cushing s Syndrome

Tundra lists 5 Cushing s Syndrome clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07920198

Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)

Primary Objective: The primary objective of the study is to characterize subjects affected by adrenal disease by collecting medical history data at diagnosis, clinical, bio-humoral, and radiological data, as well as information regarding the therapeutic approach, in terms of both potential surgical interventions and/or pharmacological therapies and hormone replacement therapies. Secondary Objective: The secondary objective is to integrate these data with current knowledge in order to improve the clinical, diagnostic, and therapeutic management of patients affected by adrenal disease, as well as to identify risk and/or predisposing factors for the development of the disease. Study Design: Observational, longitudinal, single-center, non-interventional (without drug administration) study. The study is divided into two phases: FIRST PHASE (retrospective): registration of all patients affected by hypothalamic-pituitary-adrenal disease followed by the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena. SECOND PHASE (prospective): enrollment of all patients affected by adrenal disease consecutively presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena. Study Population Inclusion criteria: subjects affected by adrenal disease presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena, who are able to autonomously provide written informed consent. Exclusion criteria: subjects under 18 years of age. Study Methodologies An anonymized database will be created to collect data from patients presenting to the aforementioned outpatient clinic. Specifically, the data collected for each patient will include: demographic data, data related to the adrenal disease, symptoms, physical examination, radiological imaging, surgical intervention data, histological examination data, bio-humoral tests, hormonal tests, DEXA data, current replacement therapies data, current anti-secretory medical therapies data, data on other current pharmacological therapies, and comorbidities data.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-09

1 state

Cushing s Syndrome
Cushing Disease
Cushing Disease Due to Increased ACTH Secretion
+19
NOT YET RECRUITING

NCT07916415

Automated Capture of Core Data for Rare Diseases and Glucocorticoid Complications: Biomarkers and Patient-Reported Outcomes

Main goal: Looking for biological markers (molecular and biochemical) that predict glucocorticoid complications using blood and urine samples. Evaluation criterion: statistical association between biological markers and the occurrence of glucocorticoid complications. Glucocorticoid-related complications are collected in a research program called "CDE.AI" (common data elements, artificial intelligence). CDE.AI aims at processing unstructured medical reports with natural language processing tools to fill in automatically forms reporting the outcome of patients with glucoocorticoid excess.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-05

Cushing s Syndrome
Glucocorticoid Effect
RECRUITING

NCT07350707

Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

In previous clinical practice, 68Ga-Pentixafor PET/CT has demonstrated promising diagnostic utility in various neuroendocrine tumors by targeting CXCR4, a chemokine receptor overexpressed in several ACTH-secreting neoplasms. Building on this, and leveraging the Nuclear Medicine expertise at Peking Union Medical College Hospital, we aim to conduct a prospective observational study investigating the role of CXCR4-targeted PET/CT imaging in patients with confirmed or suspected Cushing's syndrome. This study will focus on evaluating the capability of \^68Ga-Pentixafor PET/CT to assist in the differential diagnosis of ACTH-dependent and ACTH-independent subtypes, as well as in the localization of primary lesions in challenging cases. Imaging performance will be assessed in comparison with conventional modalities and/or 68Ga-DOTATATE PET/CT when available.

Gender: All

Ages: 10 Years - 80 Years

Updated: 2026-11-03

1 state

Cushing s Syndrome
RECRUITING

NCT06246357

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

Background: The adrenal glands are 2 small organs that sit on top of each kidney. They release hormones; these are chemicals that control how the body works. Tumors on or outside the adrenal glands are called functional if they release hormones; they are called nonfunctional if they do not. Doctors who treat adrenal tumors need to know which type a person has. Researchers want to find better ways to learn whether an adrenal tumor is functional. Objective: To see if a new radioactive tracer (\[68Ga\]Ga-PentixaFor) can make it easier to identify functional adrenal tumors with positron emission tomography (PET) scans. Eligibility: People aged 18 years and older with 1 or more adrenal tumors. They must have increased levels of the hormones aldosterone or cortisol. They must also be enrolled in at least 1 other related NIH study (protocols 19-DK-0066, 18-CH-0031, or 09-C-0242). Design: Participants will be screened. They may have imaging scans. Their ability to perform normal activities will be reviewed. Participants will have one PET scan with the study tracer. The tracer will be given through a tube attached to a needle inserted into a vein. Participants will receive the tracer 1 hour before the scan. They will lie still on a bed while a machine captures images of the inside of their body. The scan will take 45 to 90 minutes. Participants heart rate, blood pressure, and rate of breathing will be checked before, during, and after the scan. Participants will have a follow-up visit 3 days after their scan. This visit can be by phone, email, or in person.

Gender: All

Ages: 18 Years - 120 Years

Updated: 2026-10-22

1 state

Hyperaldosteronism
Hypercortisolism
Cushing s Syndrome
ENROLLING BY INVITATION

NCT07182175

Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors

The main goal of this study is to follow patients with functional adrenal tumors during the time before and after their surgery. The main questions it aims to answer are: * What heart and blood pressure changes do patients with different types of adrenal tumors have before surgery? * What factors affect how the heart and blood pressure recover after surgery? * Do the heart and blood pressure conditions before surgery influence recovery and the risk of heart or brain problems after surgery? Patients will have heart ultrasound checks and health monitoring before and after surgery. The results will help doctors choose the right medicines before surgery, better understand possible risks during the operation, and make safer treatment plans for patients with functional adrenal tumors.

Gender: All

Ages: 18 Years - Any

Updated: 2025-09-19

Primary Aldosteronism
Adrenal Tumor
Cushing s Syndrome
+1